We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
39 hedge funds and large institutions have $117M invested in Fate Therapeutics in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 2
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
125% more capital invested
Capital invested by funds: $51.9M → $117M (+$64.7M)
56% more funds holding
Funds holding: 25 → 39 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
39
Holders Change
+14
Holders Change %
+56%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
14
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$12M |
| 2 |
BC
Broadfin Capital
New York
|
+$7.36M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.72M |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$5.29M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$3.56M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$148K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$99K |
| 3 |
SIM
Spark Investment Management
New York
|
-$61K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$17K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$11.8K |
